Q1 FY27 Results: Revenue up 25% YoY, PAT jumps 41% on consol basis

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

JUBLINGREA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.6%1-day move

₹764.40

prior close

₹779.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-3.5-4.7-5.1-3.6-5.2-2.5———————

Up moveDown movePending

AI summary

Jubilant Ingrevia posted Q1 FY27 consolidated revenue of Rs 1,300 crore, up 25% YoY from Rs 1,038 crore. Consolidated PAT rose 41% to Rs 106 crore vs Rs 75 crore. Standalone PAT more than doubled to Rs 126 crore from Rs 59 crore. Operating margin improved to 11.39% from 9.76% YoY. All three segments (Speciality Chemicals, Nutrition and Health, Chemical Intermediates) posted growth. Auditor Walker Chandiok gave an unmodified review report. No exceptional items in this quarter.

Likely market impact

Strong quarter with double-digit revenue and profit growth and margin expansion. Likely positive for stock sentiment.